Cautionary Announcement – Discussions with MSD
ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number 1985/0002935/06 Share code: APN ISIN: ZAE000066692 (“Aspen” or “the Company”) CAUTIONARY ANNOUNCEMENT
Accolades
Stephen Saad named as Business Leader of the Year
STEPHEN SAAD AWARDED BUSINESS LEADER OF THE YEAR TITLE Johannesburg: Aspen Group Chief Executive, Stephen Saad, was named as the Business Leader of the Year
Aspen’s revenue increases by 23%
JSE Ltd listed Aspen Pharmacare Holdings Limited (APN), Africa’s largest pharmaceutical manufacturer, has announced pleasing results for the year ended 30 June 2012, extending its
Aspen Trading Statement
APN – Aspen Pharmacare Holdings Limited – Trading statement Aspen Pharmacare Holdings Limited (Incorporated in the Republic of South Africa) (Registration number 1985/002935/06) Share code:
Aspen Global acquires Australian product portfolio for R2.2 billion
The Aspen Group (“Aspen”) is pleased to announce that Aspen Global Incorporated (“Aspen Global”), a wholly owned subsidiary of Aspen Holdings, has reached agreement with
Judy Dlamini, Aspen Chairman’s Upper Echelon interview
“I actually want to work until the very last day of my life”, Judy Dlamini ALEC HOGG: Upper Echelon is brought to you by Deloitte
Aspen businesses activate 29 Mandela Day projects globally
Durban: Aspen, one of the world’s top 10 generic pharmaceutical companies by revenue and the largest pharmaceutical manufacturer in the southern hemisphere, is activating 29
Update on the reported key anti-retroviral (ARV) Tenofovir (TDF) public sector supply shortages
Johannesburg – over the past days and weeks, there have been widespread reports from various State Clinics, in certain provinces, that patients have been unable
Media Enquiries
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com
